chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The night after the shot, I woke up in the middle of the night in excruciating pain in my L arm. I couldn?t touch it in any way, let alone move it or lay on it. The next morning when I got up, I could not move my arm whatsoever and it was one of the worst pains I?ve ever felt. Even superficial touch to the skin anywhere on my deltoid/shoulder/bicep made me jump to the ceiling in pain. Around noon (so almost 24hrs after the shot), I developed a 100* fever, severe aches, chills, and my arm hurt worse and worse. I felt like I needed an arm/shoulder brace it hurt so bad and this went on the whole day. The next day (Tues), my arm hurt a little less but my entire deltoid was bright red, warm to the touch, enlarged, and still painful although not as much as before. As an RN, I?ve never seen or felt a reaction like this to a vaccine/medication. I?ve never reacted to anything like this before.  Oddly when I received the vaccine, I didn?t feel the injection at all.
Malaise, fatigue, muscle pain, fever, shivering, stomach pain, and nausea.
Pt. received vaccines on 9/21/10. He then started to experience headache, facial swelling & rash on chin.
Complained of "scratchy throat".  No other symptoms.  25 mg Benadryl po given.  Was observed until symptoms went away
Eyes developed thick fluid after vaccination; Lightning flashes in the left eye; This spontaneous case was reported by a consumer and describes the occurrence of VITREOUS FLOATERS (Eyes developed thick fluid after vaccination) and PHOTOPSIA (Lightning flashes in the left eye) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Floaters in eye (Patient had Floater in left eye since their 20's.).    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VITREOUS FLOATERS (Eyes developed thick fluid after vaccination) and PHOTOPSIA (Lightning flashes in the left eye). At the time of the report, VITREOUS FLOATERS (Eyes developed thick fluid after vaccination) and PHOTOPSIA (Lightning flashes in the left eye) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments.  Treatment medication was not provided. The patient had an appointment to see their retinologist on15Mar2021.
Vaccine Monday Tingling in the right foot Tuesday Swelling  Wednesday NP visit Thursday increased swelling Friday US confirmed DVT to the popliteal vein
The area become swollen and hard, red and hot. Patient took 5 days clindamycin treatment, (alternative to penicillin allergy). Today still have a hard area.
Pt states local rxn (sore arm) developed 24 hrs p/vax; no systemic rxn; reported @ this time 2mm redness site of vax; 10APR92 devel nausea, lightheadedness;
I was 30 weeks and 3 days pregnant when I got the first Pfizer Covid vaccine. I stopped feeling my baby move that day. He had been VERY active until then. On May 21, 2021 I could not find his heartbeat with my at home monitor. On May 24, 2021 it was confirmed at my doctors office that there was no heartbeat. I delivered him on May 26, 2021 at 3:22pm after being induced. He weighed 4 pounds and was 17 1/2 inches long. I was told there was a stricture in one of the blood vessels in the cord and a blood clot. My due date was July 21, 2021. Other complications during the pregnancy: He had Down?s syndrome and a condition called Duodenal atresia. Because of the duodenal atresia I had slightly higher than normal amniotic fluid.
24 hours after injection developed shaking chills, fever, headache, body aches. The symptoms lasted about 24 hours. 72 hours after injection I have red patch on arm 2 inches below injection site. Pain if pressure applied and constant itching. No rash.  Currently still going 24 hours after it started
On Saturday, 27Mar, it was Bell's Palsy paralysis of the right side of my face.; By Tuesday, 23Mar, I had an earache and sore throat.; This is a spontaneous report received from a contactable consumer (patient, self-reported). A 67-year-old female patient (who was not pregnant at the time of vaccination), received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EN6204 and expiry date was not provided), via an intramuscular route of administration, in left arm on 20Mar2021, at 14:30 as single dose for COVID-19 immunisation. Patient's medical history included breast cancer in 2009, gall bladder disorder in 2020, tonsillectomy in 1965, hysterectomy in 1986 and patient had known allergies to Latex, nail polish remover and sensitivity to fragrances. Concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (lot number: EN6198, and expiry date was not provided), via an intramuscular route of administration in left arm on 27Feb2021, at 12:30 PM as single dose for COVID-19 immunisation. No other vaccination received in past four weeks and no other medications in past two weeks of vaccination. Patient stated that by Tuesday, 23Mar2021 at 05:00, she had an earache and sore throat. On Saturday, 27Mar2021, it was Bell's Palsy paralysis of the right side of her face. As a result, the patient had to visit Emergency room/department or urgent care and physician office visit. The patient has been tested for COVID, post vaccination, on 27March 2021, which resulted as negative. The patient was treated for the adverse events with Prednisone and antiviral medicine. Outcome of the events was not recovered.
1/15/04 2cm x 2cm, circular lesion, red, warm, non tender-cellulitis. Keflex 200mg/5ml 3/4 182 bid x 10 d, received 1/16/04 same, received 1/17/04, decreased redness, same size, mac/pap x 3 at chest and back.
Patient's legs immediately began to swell, much larger than I had seen swell in his older sister.  The nurse advised me to administer ibuprofen when we got home.  From the time of vaccination, patient screamed a very high pitched scream from 2:00 PM 3/5/07 until midnight -- 10 hours straight.  He flinched at the slightest touch and pain was evident.  I called my doctor's office at approximately 3:30, and the nurse told me to administer more ibuprofen and rub the sites where he received vaccination.  I did not administer more ibuprofen as I was uncomfortable with giving him another dose, but I did rub his legs -- which proved to be completely excruciating for him to endure.  I called my doctor's office again at 5:00, but the office was closed so I called a "Call A Nurse" from the hospital.  She suggested a myriad of ridiculous suggestions from teething to gas.  I tried to nurse him several times but he would not nurse and his screams of pain would turn into gasps for air if I touched him.  At one point, I laid him on the floor and leaned over the top of him to try and nurse him.  He suckled for under a minute and continued crying.  He did not sleep or eat for 10 hours.  At approximately midnight it seemed like he began to have trouble breathing.  Strangely enough, it seemed that this calmed him down, and within a minute his breathing became regular and he fell asleep.  I called the "Ask A Nurse" again and talked to a gentleman that said I let him sleep if he's sleeping and bring him in to the doctor again the following day.  Patient slept for 15-30 minutes at a time during the night, waking up often screaming a scream I had never heard from him before.  In the morning, I called the doctor's office and talked to the nurse.  I told her what had happened since I talk to her last and she said "That sort of reaction happens often.  It might be the Pertussis part of the vaccine because it often gives people trouble.  We'll give him his next round of shots in a couple months, and if this reaction happens again we'll consider taking out the Pertussis."    Patient was not the same baby he was previously to 3/5/07.  He cried often and was inconsolable.  He always seemed like he was in pain.  I discussed my concerns with my doctor and his nurse, and they both assured me it was a normal reaction and that he was not injured or hurt long term.  They both urged me to continue vaccinating him.   Patient's behavior for the next 14 months was... odd.  He was always "touchy" and cried often as if he was always in pain.  I found him many times standing in one spot, hitting his head with his hand.  When he was about 14 months, I found him hitting his head with his hand saying "ow ow ow" with every touch to his head.  My little boy would have been a different person had he not received those vaccinations.   He passed away on 4/10/2008, unrelated to vaccinations.
Symptoms:  Vaginal bleeding and discharge (17 years post menopause) menstrual cramping. Symptoms lasted  off and on for 6 months post vaccination.
Moderna COVID-19 Vaccine EUA Days 5-6 after had low grade fever (99.4) resolved with 500mg acetaminophen.  Day 7 after had joint pain and swelling, worst in knees to cause trouble walking and bending legs gradually resolved with meloxicam over 5 days.
Headache, Myalgia, Fever, NauseaVomiting, Chills, lip and mouth blisters, fatigue Narrative:
Patient is pregnant and received the first Moderna shot on Friday; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Patient is pregnant and received the first Moderna shot on Friday) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 15-Sep-2021. On 22-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Patient is pregnant and received the first Moderna shot on Friday). On 22-Jan-2021, EXPOSURE DURING PREGNANCY (Patient is pregnant and received the first Moderna shot on Friday) had resolved.            Concomitant medication was not reported. Treatment medication was not reported.
severe Dysuria tested positive for HSV1 Genital; Low WBC count and low lymphocytes; Low WBC count and low lymphocytes; patient developed 102.6 fever; nausea; Swollen groin lymph nodes; kidney infection; severe UTI; the patient experienced bad leg pain; rash on legs; This is a spontaneous report from a contactable other hcp (patient). A 53-year-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 vaccine), dose 2 via an unspecified route of administration, administered in Arm Right on 22Apr2021 13:30 (Batch/Lot number was not reported) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included breast cancer and Hashimoto disease. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient previously received first dose of bnt162b2 at the age of 53-years-old on 01Apr2021 12:30 in the arm right for COVID-19 immunization. On 02May2021 22:00, the patient experienced bad leg pain, rash on legs, flowed by severe UTI and kidney infection. On 05May2021, day 3, the patient developed 102.6 fever, nausea, swollen groin lymph nodes, severe dysuria tested positive for HSV1 Genital, with bad lower pelvic pain, low WBC counts and low lymphocytes. The patient had 2 trips to ER in 3 days, missed 8 days of work due to the events. The patient received IV fluids, IV antibiotic, IV pain meds, anti-nausea as treatment for the events. The outcome of the event was recovered with sequel.  Information on the Lot/Batch number has been requested.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, A possible causal relationship between reported events and suspect drug BNT162B2 Cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Committees, and Investigators, as appropriate.
Patient experienced extreme dizziness, felt the world was spinning when she woke up in the middle of the night 15 hours after receiving the vaccine. Patient now has positional vertigo.
Information has been received from a pharmacist concerning a female patient, who is a medical assistant, who on 07JUL2003, also reported as 21OCT2003, was "accidentally" vaccinated IM (into the left deltoid) instead of subcutaneously with a 0.5 ml dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live. There was no concomitant medication. The patient developed a rash at the injection site. It was noted that the patient reported some copious bleeding and localized pain at the injection site. Medical attention was sought. There were no labs performed and no prescription drug required. A MMR titer was planned to be drawn. The patient's medical history was unknown. Additional information has been requested.
This is just to report that Nurse gave the patient a Pfizer vaccination instead of his second Moderna. Patient is aware and experienced no side effects
first Energix B / on 09/13/2020 / has not received her third dose of Energix B; first Energix B / on 09/13/2020 and her second Energix B / on 02/10/2021; This case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a 57-year-old female patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis, HBV (Engerix B) for prophylaxis and hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Engerix B with an associated reaction of migraine (received 1st dose of Engerix B on 13th September 2020, refer case US2021AMR086014).   On 10th February 2021, the patient received the 2nd dose of Engerix B. On 10th February 2021, the dose was an unknown dose. On 10th February 2021, the patient started Engerix B Pre-Filled Syringe Device. On an unknown date, the patient received the 3rd dose of Engerix B and Engerix B Pre-Filled Syringe Device. On 10th February 2021, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device and not applicable after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced incomplete course of vaccination. On 4th April 2021, the outcome of the drug dose administration interval too long was unknown. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follow: The patient had reported the case for herself. The age at vaccination was not reported, however it could be 56 or 57 years. The patient received 1st dose of Engerix on 13th Sep 2020. The patient received 2nd dose of engerix B on 10th Feb 2021. The patient was scheduled for 3rd dose of Engerix B on 15th Apr 2021. The patient was not aware of the schedule. Which leads to Drug dose administration interval too long and incomplete course of vaccination. The reporter did not consent for follow up with her health care professional. This case had been linked with US2021AMR086014 , reported by the same reporter for the same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR086014:Same reporter
visit to clinic w/another pt on 10AUG93, mom stated pt had a sz 24 hrs p/last vax JUN93; requiring visit to hosp ER; had complete recovery; said pt had hx febrile sz prior to immun;
Information has been received from a consumer concerning her 36 month old son with no pertinent medical history reported and no known drug allergies who in March 2007, was vaccinated with a dose of PROQUAD (Merck) (dose, route and lot number not reported). There was no concomitant medication. "Five months after receiving the vaccine", in August 2007, the consumer reported her son became autistic. Lab tests performed included "general autism testing". At the time of reporting, the patient had not recovered from the event. The patient sought medical attention by contacting many physicians. Upon internal review, became autistic was considered to be an other important medical event. No further information is available.
Patient developed fever 105 degrees - had seizure.  Seen in ER - radiographic diagnostic tests showed no abnormalities.
Moderna COVID-19 Vaccine EUA Swelling, redness, itching around injection sight
Received Pfizer COVID-19 vaccine without untoward effects on 12/18.  Given her usual allergy shot by her allergist on 12/22 (she has been receiving these for several years; I was told this is a protein antigen in a glycerine suspension).  Within 15 minutes, patient developed anaphylaxis:  generalized erythema, swelling, pruritus and  hypotension requiring epinephrine, and diphenhydramine.   Patient recovered over several hours.
A 55 year old female nurse reported that on 08/01/02, she was inadvertently squirted in her left eye with Prevnar (pneumococcal 7-valent conjugate vaccine) vaccine, prior to administration to a patient. Concomitant medication included simvastatin (Zocor). The eye was flushed well with water. On 08/02/02, the nurse reported that her left eye was "slighty reddened and irritated. "No further information was available at the date of this report.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 02/05/21pfizer,Lot#EL9264 2nd dose: 02/26/21,Pfizer,Lot# EN6203 Diagnosed covid positive:07/21/21 symptoms started:07/16/21 Exposure:Travel Symptoms:cough, runny nose.
pt recv vax 16NVO98 & father called 18NOV98 & stated child had high fever & red blotches over face, neck & chest;also stated had fever since & has chest cold;
11/18/21 presents to ED for "worsening SOB and fevers". PMHx of "HTN, OSA".
pt recv vax 30MAY97 mom called & stated temp was 104.2;MD advised mom to go to ER: WBC 11.4 had pharyngitis;MD suspect this was secondary to acute infect;
Fatigue and sore injection site- 3 hours post injection  102 fever, severe chills, fatigue, nausea, headache  - began about 12-15 hours after injection and lasted for another 24 hours  Two days after having the shot I am still experiencing a mild headache and sweating, but the fatigue has subsided.
COVID vaccine breakthrough case. Booster dose.  Dose 1: Pfizer EN6198, 02/26/2021 Dose 2: Pfizer EN6207, 03/19/2021
This spontaneous report was received from a pharmacist concerning a patient of unknown age and gender. The patient's historical condition, concurrent condition, concomitant therapy, historical drugs or allergies were not reported. On an unknown date, the patient was vaccinated with M-M-R II via the intramuscular route, rather than the subcutaneous route. Lot # M039914 and expiry date 26-SEP-2018 (strength, dose and frequency were not reported) for prophylaxis. No adverse effects were reported.  No product quality complaint was filed.
Flushing, Hot, nausea,  fever 99.9. sore arm,  entire body with aches with pain, along with head aches.
Headache, Arthralgia, Fever, ErythemaMultiform, UrticariaPruritus, NauseaVomiting, fatigue Narrative:  Other Relevant History:
Case number PHEH2014US025035, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 04-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 28 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 03 Nov 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
APPROXIMATELY FIVE MINUTES(550PM) AFTER ADMINISTRATION OF VACCINE PATIENT CAME BACK TO ME STATING THAT HE FELT FAINT. I SAT HIM DOWN AND PUT ICE PACK ON NECK. HE STILL COMPLAINED OF SWEATS AND NAUSEA AND THEN I GAVE ANOTHER ICE PACK. SLOWLY RECOVERING, I CALLED 911 AND NOTIFIED STORE MGMT OF THE  INCIDENT. EMT ARRIVED AT 601PM AND LEFT AT 615PM AFTER ASSESING PATIENT'S CONDITION AND STATE OF MIND. CONCLUDING IT WAS MORE THAN LIKELY ANXIETY
Initial unsolicited report received from a physician via patient through other company (Pfizer) (Manufacturer Report Number: 2016533800) on 07-Feb-2017. This case involves a female patient (age not reported) who was vaccinated with a dose of TETANUS TOXOID (TETANUS VACCINE) (batch number, expiry date, route and site of administration: not reported) on an unspecified date. Patient's medical history and concomitant medications were not reported. On an unspecified date, following the vaccination, patient had allergy to tetanus vaccine. Laboratory investigations and corrective treatment were not reported. The outcome of the event was not reported. List of documents held by sender: none.
My symptoms started 2 days before testing positive. I had a low grade fever, tiredness, no appetite, & headaches, bad sore throat, with a bad cough. I was prescribed PAXLOVID for my symptoms and after a few days I started to feel better.
I had a minimal sore spot from the shot; sore arm; sleep impacted; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (167798).  A 69 year-old female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "I had a minimal sore spot from the shot"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm"; SLEEP DISORDER (non-serious), outcome "unknown", described as "sleep impacted". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.